SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-159793
Filing Date
2021-05-13
Accepted
2021-05-13 06:46:02
Documents
14
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d538217d8k.htm   iXBRL 8-K 26200
2 EX-99.1 d538217dex991.htm EX-99.1 57507
6 GRAPHIC g538217g88l76.jpg GRAPHIC 22008
  Complete submission text file 0001193125-21-159793.txt   246805

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sybx-20210513.xsd EX-101.SCH 3094
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20210513_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20210513_pre.xml EX-101.PRE 11424
7 EXTRACTED XBRL INSTANCE DOCUMENT d538217d8k_htm.xml XML 3366
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 21917124
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences